FibroBiologics will present on fibroblast-based therapies for chronic diseases at a conference in Freiburg, Germany, on March 27, 2025. FibroBiologics, Inc., a biotechnology company focused on ...
Scientists are uncovering surprising complexity in connective tissues, from diverse fibroblast subtypes to collagen’s hidden ...
Renal fibrosis represents the final common pathological outcome of chronic kidney disease (CKD) and is a major determinant of progression to end-stage renal failure. A hallmark event driving renal ...
“By selectively modulating the miR-26a-5p–CCNE2 regulatory axis, this approach interrupts the signaling cascades that drive fibroblast hyperactivation and excessive matrix deposition. Importantly, the ...
Pirfenidone exosomes improve wound healing and reduce scarring in preclinical models. Discover this innovative antifibrotic therapy.
GA, UNITED STATES, March 16, 2026 /EINPresswire.com/ — Hypertrophic scars remain one of the most persistent challenges in wound healing, often resulting in ...